NCT05300165

Brief Summary

Beneficial effects of moderate chronic consumption of beer have been extensively reported, however, the mechanisms have not been elucidated yet. Gut microbiota is an important mediator in the homeostasis of the host. Polyphenols act as bacterial substrates and modulators of the gut microbiota. Indeed, the investigators have previously observed that the chronic moderate consumption of red wine by metabolic syndrome patients triggered in an amelioration of the metabolic syndrome variables, and this effect was mediated, at least partially, by the interaction of the gut microbiota with the polyphenols of the red wine. In this manner, beer has a medium content of polyphenols. Thus, the investigators propose that the beneficial effects of moderate chronic consumption of beer could be because of the action of the gut microbiota with the beer polyphenols. The investigators are going to perform an intervention study in which normal volunteers will consume three different beer types with different content in polyphenols and it will be analyzed the gut microbiota profile (Metagenomics), metabolites (Metabolomics) and metabolic syndrome markers (gene expression, ELISA) to establish the correspondent relationships, trying to decipher the implication of the gut microbiota in the beneficial effects of moderate chronic consumption of beer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2019

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 8, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 29, 2022

Completed
Last Updated

March 29, 2022

Status Verified

March 1, 2022

Enrollment Period

4 months

First QC Date

March 8, 2022

Last Update Submit

March 17, 2022

Conditions

Keywords

beer

Outcome Measures

Primary Outcomes (1)

  • Changes in gut microbiota

    change from baseline in 16S rRNA amplicons determined in DNA from feces after 6 weeks

    Baseline, 2nd, 4th and 6th weeks visits

Secondary Outcomes (6)

  • Change in caloric consumption

    Baseline and 6th weeks visits

  • Change in waist circumference

    Baseline and 6th weeks visits

  • Change in glucose concentration

    Baseline and 6th weeks visits

  • Change in HDL-cholesterol concentration

    Baseline and 6th weeks visits

  • Change in triglycerides concentration

    Baseline and 6th weeks visits

  • +1 more secondary outcomes

Study Arms (1)

Normal population

OTHER

20 participants representing a normal population will include a daily beer in their meals, changing the kind of beer every 2 weeks from alcohol-free lager beer, lager beer, or dark beer.

Dietary Supplement: Beer

Interventions

BeerDIETARY_SUPPLEMENT

A daily beer will be consumed by the participants during a total of 6 weeks, changing every 2 weeks from alcohol-free lager beer, lager beer and dark beer

Normal population

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Usual consumer of Beer

You may not qualify if:

  • being a non usual beer-consumer,
  • body mass index (BMI) \> 40 kg m2.
  • acute or chronic infection, inflammatory disease or endocrine disorders; history of cancer; leukocytosis; anti-inflammatory, corticosteroid or hormone treatment.
  • history of alcohol abuse or drug dependence.
  • under a restrictive diet or a weight change ≥5 kg during the 3 months prior to the study.
  • antibiotic therapy, prebiotics, probiotics, synbiotics, vitamin supplements or any other medical treatment influencing intestinal microbiota during the 3 months before the start of the study or during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Virgen de la Victoria

Málaga, 29010, Spain

Location

MeSH Terms

Interventions

Beer

Intervention Hierarchy (Ancestors)

Alcoholic BeveragesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFermented BeveragesFermented FoodsFood and Beverages

Study Officials

  • Francisco J. Tinahones, PhD

    Instituto de Investigacion Biomedica de Malaga

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2022

First Posted

March 29, 2022

Study Start

February 13, 2019

Primary Completion

June 19, 2019

Study Completion

December 30, 2020

Last Updated

March 29, 2022

Record last verified: 2022-03

Locations